Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,178.00    -4.00 (-0.18%)
Bid:
2,192.00
Ask:
2,220.00
Spread: 28.00 (1.277%)
Market Cap: £1.45b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

31 Dec 2013 12:41

RNS Number : 6678W
Genus PLC
31 December 2013
 



31 December 2013

 

 

Genus plc

("Genus" or the "Company")

 

Director/PDMR Shareholdings

 

As described in the Genus 2013 Annual Report, following the introduction of compulsory deferral of 25% of annual bonus earned by Executive directors and members of the Genus Executive Leadership Team ("GELT"), in respect of bonuses earned in the financial year ending 30 June 2013, Genus announces that nil cost options were awarded yesterday under the Genus Deferred Share Bonus Plan (the "Plan") to:

 

· Karim Bitar, Chief Executive, as to 3,495 ordinary shares of 10 pence each in the Company ("Shares");

 

· Stephen Wilson, Group Finance Director, as to 1,050 Shares;

 

· Bill Christianson, Chief Operating Officer, Genus PIC, as to 1,132 Shares;

 

· Saskia Korink Romani, Chief Operating Officer, Genus ABS, as to 487 Shares;

 

· Jerry Thompson, Chief Operating Officer, Genus Asia, as to 2,092 Shares; and

 

· Catherine Glickman, Group Human Resources Director, as to 1,014 Shares.

 

 

Subject to the terms of the Plan and the grantee's continued service, the awards will ordinarily vest on 27 September 2016.

 

No consideration was paid for the grant of these awards and no consideration is due in connection with the exercise of these awards.

 

On the same date, in accordance with the terms of joining contained in their respective employment contracts, the following GELT members were granted contingent rights over Shares under individual award agreements as follows:

 

· Saskia Korink Romani, Chief Operating Officer, Genus ABS, as to 2,076 Shares with a normal vesting date of 7 January 2015; and

 

· Jonathan Lightner, Chief Scientific Officer, as to 8,918 Shares with a normal vesting date of 21 October 2014 as to 4,459 Shares and 21 October 2015 as to 4,459 Shares.

 

Subject to the terms of the individual award agreements and the relevant grantee's continued service, the awards will ordinarily vest on the normal vesting date for the awards as specified above.

 

No consideration was paid for the grant of these awards and no consideration is due in connection with the exercise of these awards.

 

This notification is made in accordance with DR 3.1.4R(1)(a).

 

 

 

For further information please contact:

 

Cara Crichton

Deputy Company Secretary

Genus plc

 

Tel: 01256 347100

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUAOUROKAUOAA
Date   Source Headline
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.